Live-attenuated Chikungunya vaccine: a possible new era

被引：0
|
作者：
Stephenson, Kathryn E. [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA
来源：
LANCET | 2023年 / 401卷 / 10394期
关键词：
VIRUS;
D O I：
10.1016/S0140-6736(23)01170-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2090 / 2091
页数：2
相关论文
共 50 条
  • [41] Engineering a new vaccine platform for heterologous antigen delivery in live-attenuated Mycobacterium tuberculosis
    Broset, Esther
    Calvet Seral, Juan
    Arnal, Carmen
    Uranga, Santiago
    Kanno, Alex, I
    Leite, Luciana C. C.
    Martin, Carlos
    Gonzalo-Asensio, Jesus
    [J]. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 4273 - 4283
  • [42] Characterization of a live-attenuated HCMV-based vaccine platform
    Caposio, Patrizia
    van den Worm, Sjoerd
    Crawford, Lindsey
    Perez, Wilma
    Kreklywich, Craig
    Gilbride, Roxanne M.
    Hughes, Colette M.
    Ventura, Abigail B.
    Ratts, Robert
    Marshall, Emily E.
    Malouli, Daniel
    Axthelm, Michael K.
    Streblow, Daniel
    Nelson, Jay A.
    Picker, Louis J.
    Hansen, Scott G.
    Fruh, Klaus
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [43] Reverse genetic platform for inactivated and live-attenuated influenza vaccine
    Jung, Eun-Ju
    Lee, Kwang-Hee
    Seong, Baik Lin
    [J]. EXPERIMENTAL AND MOLECULAR MEDICINE, 2010, 42 (02): : 116 - 121
  • [44] Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design
    VanBuskirk, Kelley M.
    O'Neill, Matthew T.
    De la Vega, Patricia
    Maier, Alexander G.
    Krzych, Urszula
    Williams, Jack
    Dowler, Megan G.
    Sacci, John B., Jr.
    Kangwanrangsan, Niwat
    Tsuboi, Takafumi
    Kneteman, Norman M.
    Heppner, Donald G., Jr.
    Murdock, Brant A.
    Mikolajczak, Sebastian A.
    Aly, Ahmed S. I.
    Cowman, Alan F.
    Kappe, Stefan H. I.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (31) : 13004 - 13009
  • [45] Reverse genetic platform for inactivated and live-attenuated influenza vaccine
    Eun-Ju Jung
    Kwang-Hee Lee
    Baik Lin Seong
    [J]. Experimental & Molecular Medicine, 2010, 42 : 116 - 121
  • [46] Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery
    Lin, Ivan Y. C.
    Thi Thu Hao Van
    Smooker, Peter M.
    [J]. VACCINES, 2015, 3 (04) : 940 - 972
  • [47] First-in-human trial of a live-attenuated Mycobacterium tuberculosis vaccine
    Geldmacher, Christof
    Hatherill, Mark
    [J]. LANCET RESPIRATORY MEDICINE, 2015, 3 (12): : 906 - 907
  • [48] Prior DNA vaccination does not interfere with the live-attenuated measles vaccine
    Premenko-Lanier, M
    Rota, P
    Rhodes, G
    Bellini, W
    McChesney, M
    [J]. VACCINE, 2004, 22 (5-6) : 762 - 765
  • [49] Stabilizing formulations for inhalable powders of live-attenuated measles virus vaccine
    Burger, Jessica L.
    Cape, Stephen P.
    Braun, Chad S.
    Mcadams, David H.
    Best, Jessica A.
    Bhagwat, Pradnya
    Pathak, Pankaj
    Rebits, Lia G.
    Sievers, Robert E.
    [J]. JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2008, 21 (01) : 25 - 34
  • [50] Subgenomic flavivirus RNA as key target for live-attenuated vaccine development
    Doets, Kristel
    Pijlman, Gorben P.
    [J]. JOURNAL OF VIROLOGY, 2024, 98 (07)
12345